ALNY
Alnylam Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$266.11
+0.61%Leverage
- Debt / equity
- 0.94x
- Net debt / equity
- -0.33x
- Debt / assets
- 0.23x
- Debt / EBITDA
- 1.10x
- Net debt / EBITDA
- -0.38x
Liquidity & coverage
- Current ratio
- 3.05x
- Quick ratio
- 2.99x
- Cash ratio
- 2.19x
- Interest coverage
- 3.08x
- EBITDA / interest
- 3.54x
- Working capital
- $3.1B
Cash & dividend
- FCF / debt
- 0.43x
- Cash flow / debt
- 0.50x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026